openPR Logo
Press release

Lawsuit filed for Investors in shares of Becton, Dickinson and Company (NYSE: BDX)

03-04-2020 04:19 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Becton, Dickinson and Company (NYSE: BDX) shares.

A lawsuit was filed on behalf of investors in Becton, Dickinson and Company (NYSE: BDX) shares.

An investor, who purchased shares of Becton, Dickinson and Company (NYSE: BDX), filed a lawsuit over alleged violations of Federal Securities Laws by Becton, Dickinson and Company.

Investors who purchased shares of Becton, Dickinson and Company (NYSE: BDX) have certain options and for certain investors are short and strict deadlines running. Deadline: April 27, 2020. NYSE: BDX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On February 6, 2020, Becton, Dickinson and Company lowered its fiscal 2020 guidance, expecting revenue to increase by only 1.5 to 2.5 percent, "to reflect the impact of the remediation effort and anticipated loss of sales of the Alaris infusion system." According to the Company, the software remediation plan for the Alaris system "will require additional regulatory filings," and existing customers would have "access to the Alaris System under medical necessity."

The plaintiff claims that between November 5, 2019 and February 5, 2020, the defendants failed to disclose to investors that certain of Becton's Alaris infusion pumps experienced software errors and alarm prioritization issues, that, as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to "make enhancements", that the Company was reasonably likely to face regulatory delays in connection with the software remediation, that, as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Those who purchased shares of Becton, Dickinson and Company (NYSE: BDX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Becton, Dickinson and Company (NYSE: BDX) here

News-ID: 1954911 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Becton

Cell-based Assay Market Growth in Future Scope 2022-2028 | DiscoverX Corporation …
The Cell-based Assay Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Cell-based Assay Market report is to supply an in-depth view and strategic analysis of the parent industry. The report examines each segment also as their respective sub-segments present within the market in an all-inclusive manner. The report provides a deep
Neonatal Monitoring Devices Market 2020 Key Competitors Analysis: Becton, GE Hea …
Global Neonatal Monitoring Devices Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. The market research and analysis conducted in this report assist clients in forecasting the investment in an emerging market, growth of market share or success of a new product. In addition, Neonatal Monitoring Devices Market report endows with a delegate overview of the market where it identifies industry trends, determines brand
Pill Dispensers Market Growing Demand, Business Guideline and Manufacturers | Ba …
Advance Market Analytics released the research report of Pill Dispensers Market, offers a detailed overview of the factors influencing the global business scope Pill Dispensers Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Pill Dispensers Market. This Report covers the emerging player’s data, including: competitive
Blood Collection Market 2019 by Top Companies Qiagen, Becton Dickinson, Abbott L …
The Blood Collection Market was worth USD 7.06 billion in 2014 and is expected to reach approximately USD 11.35 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 5.42% during the forecast period. Expanding prevalence of infectious and non-communicable sicknesses, rising number of trauma and accident cases are the main considerations contributing toward the development. Expanding number of surgeries is another main consideration significantly advancing
Cell-based Assay Market Adopts Innovation to Stay Competitive Forecast with Top …
Cell-based assay refers to experiments based on living cells and is an influential tool in the research lab. Cell-based assays are vital for understanding cellular mechanism in a biological context as these assays provide information about intracellular molecular targets. There are variety of assays used to measure motility, toxicity, cell proliferation, production of a measurable product, and morphology. Cell-based assays provides accuracy in obtaining the data of various parameters of
Safety Needles Market Opportunity By 2027 | B. Braun Melsungen AG, Novo Nordisk …
The sole purpose of designing safety needles was to avoid needlestick injuries while collecting fluids and delivering drugs to the body. The key players of global market for safety needles are enhancing their product portfolio by focusing on production of innovative needles with safety features. These players include B. Braun Melsungen AG, Novo Nordisk A/S, Medtronic, and Becton, Dickinson and Company. Becton, Dickinson and Company holds its dominance in the